Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bellerophon Ther Com (BLPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 124,155
  • Shares Outstanding, K 55,180
  • Annual Sales, $ 0 K
  • Annual Income, $ -23,810 K
  • 36-Month Beta -0.37
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.33

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.36 +71.32%
on 11/15/17
2.44 -4.51%
on 12/04/17
+0.83 (+55.33%)
since 11/13/17
3-Month
1.02 +128.43%
on 09/15/17
2.44 -4.51%
on 12/04/17
+1.29 (+124.04%)
since 09/13/17
52-Week
0.48 +385.42%
on 12/15/16
2.44 -4.51%
on 12/04/17
+1.82 (+356.86%)
since 12/13/16

Most Recent Stories

More News
Bellerophon Appoints Ted Wang, Ph.D., of Puissance Capital Management, to its Board of Directors

Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced the appointment of Ted Wang, Ph.D., Chief Investment Officer of Puissance Capital Management, to...

BLPH : 2.33 (+3.56%)
Bellerophon Provides Business Update and Reports Third Quarter 2017 Financial Results

Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today provided a business update and reported financial results for the third quarter ended September 30, 2017.

BLPH : 2.33 (+3.56%)
Bellerophon Announces $23 Million Private Placement

Financing will support the continued development of the company's INOpulse platform with Phase 3 clinical trials in Pulmonary Arterial Hypertension and Phase 2 trials in Pulmonary Hypertension associated...

BLPH : 2.33 (+3.56%)
Bellerophon Therapeutics to Provide Corporate Update at Two Investor Conferences

Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that Fabian Tenenbaum, President and Chief Executive Officer, will provide a corporate overview at...

BLPH : 2.33 (+3.56%)
Bellerophon Announces Positive Top Line Phase 2 Data of INOpulse(R) for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease

Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced positive top line data from a Phase 2 clinical trial evaluating INOpulse(R) in patients with Pulmonary...

BLPH : 2.33 (+3.56%)
Bellerophon Announces FDA Agreement on Phase 2b Study Design for INOpulse(R) in Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced agreement with the U.S. Food and Drug Administration (FDA) on the Phase 2 study design for INOpulse(R)...

BLPH : 2.33 (+3.56%)
Biotech Stock Performance Review -- Alder Biopharma, Ardelyx, Bellerophon Therapeutics, and Corbus Pharma

If you want a Stock Review on ALDR, ARDX, BLPH or CRBP then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Today's research on DailyStockTracker.com...

CRBP : 7.20 (+2.13%)
ALDR : 11.05 (+5.24%)
ARDX : 6.05 (+4.31%)
BLPH : 2.33 (+3.56%)
Positive Clinical Data on INOpulse(R) Presented at the American Thoracic Society 113th International Conference

Acute and Chronic Benefits Demonstrated with INOpulse in Patients with PH-IPF; Patients Achieved Statistically Significant Increases in Blood Vessel Volume; Consistent Improvements were Observed in Hemodynamics,...

BLPH : 2.33 (+3.56%)
The Difference Between Spectacular News and No News

NEW YORK, NY / ACCESSWIRE / March 21, 2017 / Biotech firms are speculative in many ways, especially when investing in lower priced stocks. FDA trials can take a nose dive, resulting in the stock price...

ESPR : 57.13 (+1.87%)
BLPH : 2.33 (+3.56%)
Bellerophon Reports Fourth Quarter 2016 Financial Results and Provides Business Update

Bellerophon Therapeutics, Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today provided a business update and reported financial results for the fourth quarter and full year ended December...

BLPH : 2.33 (+3.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Bellerophon Therapeutics LLC is a biotherapeutics company. It is focused on developing products for the treatment of cardiopulmonary and cardiac diseases. The company's product pipeline consists of INOpulse and BCM which are in different clinical stage. Bellerophon Therapeutics LLC is based in Hampton,...

See More

Key Turning Points

2nd Resistance Point 2.46
1st Resistance Point 2.40
Last Price 2.33
1st Support Level 2.26
2nd Support Level 2.18

See More

52-Week High 2.44
Last Price 2.33
Fibonacci 61.8% 1.69
Fibonacci 50% 1.46
Fibonacci 38.2% 1.23
52-Week Low 0.48

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.